A non-contact laser imaging system could help doctors diagnose and treat eye diseases that cause blindness much earlier than is now possible.
glaucoma
Eye Implant Smaller Than a Grain of Sand Could Revolutionize the Treatment of Glaucoma
The US Food and Drug Administration (FDA) has approved Allergan’s drug-releasing implant, Durysta, for administration within the cavities of the eye to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
ThirdEye Partners with NuEyes to Launch the Next Generation Smart Glasses
ThirdEye, a leader in augmented reality (AR) and mixed reality (MR) enterprise solutions recently announced a new partnership with NuEyes, a pioneer in the field of low-vision technology.
Comcast Partners with NuEyes to Offer TV for Visually Impaired Customers
Comcast is partnering with wearable technology startup NuEyes to offer its Xfinity Stream app to visually impaired customers through NuEyes’ virtual reality technology.
This Injectable Sensor Constantly Monitors Glaucoma
When someone has glaucoma, there’s always a danger that pressure caused by fluid accumulating within the eye will damage the optic nerve, resulting in blindness. The Injectsense implant is designed to help, by constantly monitoring a recipient’s intraocular pressure or IOP, for short.
Artelus Is Using AI to Help People from Going Blind
Rajarajeshwari Kodhandapani has a dream, to screen one million people for diabetic retinopathy (DR) so they can get timely treatment and not risk going blind. She is one of the four co-founders of Artelus, along with tech veterans Vish Durga, Lalit Pant, and Pradeep Walia, who is also a serial entrepreneur. As a former business analyst, she never thought she would become an entrepreneur (though she did want to become a politician at one time). Now, she is part of Artelus, a company that builds advanced screening tools to allow doctors and hospitals to diagnose a greater number of patients in the same time for a variety of diseases.
15 Minute Laser Treatment Saves a Lifetime Use of Eye Drops
This 15-minute treatment reduces fluid pressure within the eye using lasers for patients with glaucoma.
Research Reveals Gene Mutation Behind Glaucoma
For the first time, a cause behind pigmentary glaucoma—one of the leading causes of blindness in adults—has been revealed by a global team of researchers from the University of Alberta, Harvard University and Flinders University in Australia.
New Laser Technology Could Treat Eye Diseases Like Macular Degeneration and Glaucoma
A platform that combines cutting-edge diagnostic tools and ultra-fast laser technology developed at the University of Alberta could usher in a new era of non-invasive medical interventions for eye diseases.
eSight Drops Price by 40 Percent
eSight, the makers of the eSight electronic glasses, is permanently dropping the pricing of its eSight glasses from $10,000 USD to $5,950 USD.
You must be logged in to post a comment.